Citicoline oral solution in glaucoma: is there a role in slowing disease progression?

Purpose: To assess the effect of citicoline on visual field rates of progression in patients with progressing glaucoma.

Patients And Methods: Forty-one patients with a diagnosis of progressing glaucoma received citicoline in oral solution for 2 years. Included were patients with a disease progression of at least -1 dB/year (at MD, mean deviation) for at least 3 years before entering the study despite controlled intraocular pressure (IOP).